Share this on:
 E-mail
13
VIEWS
0
COMMENTS
 
SHARES
About this iReport
  • Not vetted for CNN

  • Click to view GuardianSrb's profile
    Posted May 29, 2014 by
    GuardianSrb

    More from GuardianSrb

    Serbian biggest and only country-own pharm company is being recapitalized from Arabian and Ukrainian largest companies

     
    Arabian "Julfar Pharmacy" and Ukrainian "Arterium" are interested for an strategic partnership with Serbian biggest pharm company "Galenika".

    "Julfar" is interested in the production of insulin in Zemun, which otherwise hasn't been produced in Serbia. This factory is a leading manufacturer of inuslin in North Africa and Asia, and its arrival in Serbia would be its penetration into Europe.

    "Julfar" was founded in 1980 and forms part of the pharmaceutical group "Galf" from the Emirates. Factory has about 2,000 workers and just last year has sold total drugs worth of 271 million euros reaching a profit of 45.5 million euros. "Julfar" produces 470 different drugs, most of them being insulin, antibiotics, drugs for the cardiovascular, pulmonary and skin diseases.


    Ukrainian pharmaceutical company "Arterium", a national leader in the production of antibiotics and a significant producer of medicines based on herbs, is interested to build a plant for the production of infusion solutions and natural remedies in Serbia. It has 1,000 employees and produces 140 drugs. Its main exports are to Kazakhstan, Uzbekistan, Belarus and Russia.

    "Galenika" would give the staff, brand and potential, while the Ukrainians and Arabs would have to invest the capital, providing their technology and patented products.

    Serbian company has confirmed that has held two meetings with the "Julfar". The management said talks were held on a joint investment in a new plant.

    In the office of the General Director Zivomir Novakovic have said that they have been in "a long talk with Arterium".

    "We have signed a letter of intent. So far, the main topics are on exports to Ukraine and processing of a solid pharmaceutical preparations in our factory."
    • TAGS:

    What do you think of this story?

    Select one of the options below. Your feedback will help tell CNN producers what to do with this iReport. If you'd like, you can explain your choice in the comments below.
    Be and editor! Choose an option below:
      Awesome! Put this on TV! Almost! Needs work. This submission violates iReport's community guidelines.

    Comments

    Log in to comment

    iReport welcomes a lively discussion, so comments on iReports are not pre-screened before they post. See the iReport community guidelines for details about content that is not welcome on iReport.

    Add your Story Add your Story